drugset
drugset / Trial / NCT06985134

Comparative Efficacy and Safety of Thalidomide and Sulfasalazine in Moderate to Severe Ankylosing Spondylitis: A Real-World Study From Bangladesh

NCT06985134 ↗

Phase 3 Completed 93 enrolled Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
NaSingle-groupOpen-labelTreatment

Summary

the present study was conducted to determine the comparative efficacy and safety of thalidomide and SSZ in moderate to severe cases of ankylosing spondylitis in Bangladesh.

Timeline

Start
2017-01-01
Primary completion
2018-12-31
Completion
2018-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Sulfasalazine Small molecule — —
Subject Thalidomide Other / unclassified — —

Indications

spondyloarthropathy